The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC).
 
Sean Matthew McBride
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen
 
Eric Jeffrey Sherman
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Loxo; Novartis
Research Funding - Eisai; Plexxikon; Roche/Genentech
 
C. Jillian Tsai
No Relationships to Disclose
 
Shrujal S. Baxi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Jahan Aghalar
No Relationships to Disclose
 
Juliana Eng
No Relationships to Disclose
 
Wanqing Iris Zhi
No Relationships to Disclose
 
Daniel Curtis McFarland
No Relationships to Disclose
 
Loren S. Michel
No Relationships to Disclose
 
Daniel Spielsinger
No Relationships to Disclose
 
Zhigang Zhang
No Relationships to Disclose
 
Jessica Flynn
No Relationships to Disclose
 
Lara Dunn
Research Funding - Pfizer; Regeneron
 
Alan Loh Ho
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Genzyme; Kura Oncology; Merck; Novartis; Novartis; oncology consortium; Regeneron; Sun Pharma; Sun Pharma; TRM Oncology
Speakers' Bureau - Medscape; Omniprex America
Research Funding - Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Genentech/Roche; Kolltan Pharmaceuticals; Kura Oncology; Lilly
Travel, Accommodations, Expenses - Ignyta; Janssen Oncology; Kura Oncology; Merck
 
Nadeem Riaz
No Relationships to Disclose
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; Exelixis; Genentech/Roche; Incyte; Lilly; MedImmune; Merck; Novartis
 
Nancy Y. Lee
Consulting or Advisory Role - Lilly; Merck; pfizer; Vertex